AT 130

Known as: AT-130, AT130 cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2016
01220022016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Hepatitis C is an infectious liver disease with high mortality rate which is caused by Hepatitis C virus. Several… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2016
2016
Hepatitis B virus (HBV) chronically infects millions of people worldwide and is a major cause of serious liver diseases… (More)
  • table 1
  • table 2
  • table 3
  • figure 3
  • figure 1
Is this relevant?
2013
2013
Hepatitis B virus (HBV) is a major cause of liver disease. Assembly of the HBV capsid is a critical step in virus production and… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Assembly effectors are small molecules that induce inappropriate virus capsid assembly to antiviral effect. To identify… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
2011
2011
Long-term treatment of chronic hepatitis B with nucleos(t)ide analogs can lead to the emergence of HBV resistant mutants of the… (More)
Is this relevant?
2007
2007
Nucleos(t)ide analogue antiviral therapy for chronic hepatitis B has proven to be effective in the short term but the frequent… (More)
Is this relevant?
2002
2002
The phenylpropenamide derivatives AT-61 and AT-130 are nonnucleoside analogue inhibitors of hepatitis B virus (HBV) replication… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?